NRGN and Alzheimer disease: Increased levels of CSF neurogranin (Ng) and growth‐associated protein 43 (GAP‐43) were found to be linked to elevated brain metabolism but reduced cortical thickness in AD‐affected brain areas, indicating they may be more closely linked to synaptic dysfunction than other markers of brain metabolic and structural changes.23